Conference: Quantitative Systems Pharmacology Conference
Date: April 8 - 10, 2026
Location: Leiden, the Netherlands
Booth: 1
Presenters: Josh Apgar, Andrew Matteson
When: Tuesday, April 7th, 2026 | 11:30 AM – 5 PM
Where: Fletcher Wellness-Hotel Leiden (Bargelaan 180, 2333 CW Leiden, Netherlands)
Agenda:
- 11:30 AM Registration and Lunch
- 1 PM – 5 PM Workshop
QSP at Scale with Certara IQ
Lunch, snacks, and coffee are provided.
With hundreds of FDA and EMA submissions supported by QSP models, QSP has finally come of age. The now-proven high return of investment from QSP has led to every major pharma company and a significant number of biotechs investing in QSP groups or partnering with QSP vendors. However, the vast majority of preclinical and clinical programs are still not supported by QSP. At this point, we see this not as a limitation of the value of QSP but as a challenge for implementing QSP at scale. This workshop will unveil Certara IQ™, an innovative QSP environment that enables the scaling of QSP from only supporting a small minority of projects to supporting the entire pipeline. We will focus on four key decision points in the drug development pipeline:
- New Target Feasibility
- Determining Best in Class Properties
- First In Human Dose Projection
- Recommended Phase 2 Dose
For each, we will demonstrate how to use Certara IQ to efficiently answer these questions with practical examples.
Registration to the workshop is limited to 50 people and subject to approval.
Register for the Certara IQ workshop
Joshua Apgar, PhD
VP, Head of QSP SoftwareBefore co-founding Applied BioMath, Josh was a Principal Scientist in the Systems Biology Group of the Department of Immunology and Inflammation at Boehringer Ingelheim Pharmaceuticals. His work leveraged physics-based models to: translate in vitro and in vivo data, assess target feasibility, understand drug mechanism of action, and predict human doses. The ultimate goal of this work was to reduce late stage attrition in drug development through a deep and quantitative interrogation of drug pharmacology and disease pathophysiology.
Josh received his PhD from MIT in Biological Engineering where he worked on experiment design for Systems Biology, focusing on the identification of tractable experiments that could allow for the estimation of unknown parameters and reveal complex mechanisms in signal transduction networks. Before that Josh worked at Avaki to develop a highly scalable software platform to support High Performance Computing, and Enterprise Information Integration in the Life Sciences, and Engineering.
Andrew Matteson
Sr Director of Product, QSPCertara’s presence at QSPC
QSPC 2026 brings together leading scientists, modelers, and decision-makers from academia, industry, and regulatory agencies to:
- Explore emerging computational QSP approaches
- Discuss advances in mechanism- and physiologically-based PK/PD
- Share insights through plenary lectures, poster presentations, and networking sessions
Join us at the booth #1 (Apr 8 – 10): We will be hosting live demos of Certara IQ at our booth. Join us to watch the software in action!
Certara posters at QSPC 2026: Certara scientists and collaborators will be presenting new work across multiple therapeutic and methodological areas.
Planned poster presenters and highlights:
- Viji Chelliah
- Suruchi Bakshi
- Jonas Denk
- Sirin Yonucu
- Amy Kent
- James Wade
- Chris Morris
- Vicky Kostiou
- Andrew Matteson
Connect with Certara at QSPC 2026
Meet with Certara’s QSP experts at QSPC 2026 for a focused 1:1 conversation to discuss how scalable QSP can support better decisions across your drug development pipeline.
What We Can Help You With
- Where and how QSP can add the most value in your pipeline
- Scaling QSP beyond a small number of programs
- Applying QSP to key decisions (FIH dose, Phase 2 dose, target feasibility)
- Integrating QSP with PBPK and existing modeling workflows
- Evaluating whether Certara IQ is right for your organization
